Federal grants to Fimbrion Therapeutics Inc
Fimbrion Therapeutics Inc in Saint Louis, Missouri received $5.4 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Allergy and Infectious Diseases Research, with $5.4 million. In fiscal 2025 it was awarded $900,001.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.4 million
- Awards7
- Awarded in FY 2025$900,001
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $293,050 |
| FY 2022 | 1 | $1.0 million |
| FY 2023 | 3 | $1.6 million |
| FY 2024 | 3 | $1.6 million |
| FY 2025 | 3 | $900,001 |
Programs that fund Fimbrion Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 7 | $5.4 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $5.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Heterocyclic inhibitors of qcrb as novel drugs for tuberculosis - project summary/abstract 1 tuberculosis (TB), caused by infection with the bacterium mycobacterium tuberculosis (MTB), is a leading 2 cause of mortality due to infection, globally. In 2019, 10 million people were newly diagnosed with | Allergy and Infectious Diseases Research | December 8, 2021 | $3.0 million |
| Fimh-targeting antibody-recruiting molecules as novel drugs for preventing complicated urinary tract infections - 1 abstract. Urinary tract infections (UTI) are extremely common world-wide, and can lead to serious 2 complications, including renal scarring and urosepsis. Standard-of-care treatments r | Allergy and Infectious Diseases Research | February 28, 2023 | $600,000 |
| Thiazolino-pyridone compounds as novel drugs for tuberculosis - project summary/abstract tuberculosis (TB), caused by infection with the bacterium mycobacterium tuberculosis (MTB), is a leading cause of mortality due to infection, globally. In 2020, 10 million people were newly diagnosed with tb and | Allergy and Infectious Diseases Research | March 8, 2023 | $600,000 |
| Heterocyclic inhibitors of qcrb as novel drugs for infections caused by nontuberculous mycobacteria - project summary/abstract non-tuberculosis mycobacteria (NTM) are a diverse group of environmental bacteria and opportunistic pathogens capable of causing numerous human infections, the most common o | Allergy and Infectious Diseases Research | July 23, 2025 | $300,001 |
| Thiazolino-pyridone compounds as novel antimycobacterial drugs for tuberculosis - project summary/abstract tuberculosis (TB), caused by infection with the bacterium mycobacterium tuberculosis (MTB), is a leading cause of global mortality, due to infection. In 2022, ~10.6 million people were newly di | Allergy and Infectious Diseases Research | September 9, 2025 | $300,000 |
| Small molecule glycoside inhibitors of lecb for the treatment of pseudomonas infections - project summary/abstract pseudomonas aeruginosa (PA) is a gram-negative bacterium and opportunistic pathogen capable of persisting in diverse environments and causing numerous human infections including: skin, | Allergy and Infectious Diseases Research | August 15, 2025 | $300,000 |
| Heterocyclic inhibitors of qcrb as novel drugs for tuberculosis | Allergy and Infectious Diseases Research | November 30, 2020 | $293,050 |
Questions people ask
How much federal grant money does Fimbrion Therapeutics Inc get?
$5.4 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Fimbrion Therapeutics Inc the most?
The Department of Health and Human Services, with $5.4 million in 7 awards.
What is Fimbrion Therapeutics Inc's largest federal grant?
$3.0 million under Allergy and Infectious Diseases Research, with its first action in the period on December 8, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Saint Louis
- The Washington University
- The Bi State Development Agency of the Mo IL Metro Dist
- City of St. Louis
- The City of St Louis
- Icl Specialty Products Inc
- Saint Louis University
- St. Louis County, Missouri
- St. Louis Housing Authority
Largest federal grant recipients in Missouri · Federal grants in Missouri